ZYUS Life Sciences Corporation (TSXV:ZYUS)
Canada flag Canada · Delayed Price · Currency is CAD
0.6500
0.00 (0.00%)
At close: Nov 27, 2025

ZYUS Life Sciences Ratios and Metrics

Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Nov '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
527063---
Market Cap Growth
-26.54%11.19%----
Enterprise Value
677765---
Last Close Price
0.650.940.90---
PS Ratio
111.93145.32179.10---
PB Ratio
-4.01-13.082.72---
P/TBV Ratio
--12.77---
EV/Sales Ratio
143.73161.10184.09---
Debt / Equity Ratio
-1.17-2.270.427.361.020.32
Asset Turnover
0.020.020.010.000.00-
Inventory Turnover
1.241.080.760.200.01-
Quick Ratio
0.050.130.490.030.111.35
Current Ratio
0.100.190.710.440.782.34
Return on Equity (ROE)
-3516.83%-380.47%-305.81%-164.77%-67.78%-
Return on Assets (ROA)
-41.04%-35.05%-22.77%-15.46%-19.44%-
Return on Capital (ROIC)
-73.56%-49.66%-33.37%-23.08%-26.09%-
Return on Capital Employed (ROCE)
304.20%583.00%-68.30%-33.10%-37.60%-31.90%
Earnings Yield
-64.83%-48.37%-67.75%---
FCF Yield
-20.63%-14.19%-29.00%---
Buyback Yield / Dilution
-6.48%-28.41%-45.82%24.99%-5.35%-
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.